About Nicholas Valeriani
Form D filings for SPR Therapeutics from 2017 to 2024 list Nicholas Valeriani as director.
Nicholas Valeriani first appears on SEC filings in 2017.
Experience
This experience comes from SEC filings. The years are when the filings name Nicholas Valeriani in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Nicholas Valeriani works with at each company, as listed on that company's latest Form D.
SPR Therapeutics, Inc. · Form D, Feb 5, 2024
JB
Josh Boggs
Executive officer
MC
Michael Chuisano
Director
GT
Geoffrey Thrope
Director
BA
Ben Austin
CFO
MB
Maria Bennett
Executive officer and director
RB
Robert Blankenship
Director